Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the history and removed Revision: v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The history now includes an added Revision: v3.4.2 and the previous funding-status notice was removed, with no changes to the actual study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T10:59:24.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:25:15.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a glossary and color-coded highlights (green for additions, red for deletions) and updates the revision label to v3.4.0; the previous No FEAR Act data and v3.3.4 label were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-01-28T04:56:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.3.3 to v3.3.4 in the UI. There are no visible changes to the study history content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:24:33.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added and the entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:31:02.000Z thumbnail image

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.